Perfetti Riccardo's Form 4 filing
Applied Therapeutics, Inc. (APLT) · filed Jul 29, 2021
- Accession no.
- 0001209191-21-048710
- Filed
- Jul 29, 2021
- Trade date
- Jul 27-29, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 3 derivative transactions. Open-market sales total $778.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Perfetti RiccardoCIK 0001775410 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2021 | Common Stock | MOption exerciseAcquired | +15,000 | $1.44 | +$21,600 | 15,000 | Direct | |
| Jul 27, 2021 | Common Stock | SSaleDisposed | −7,776 | $17.05F3 | −$132,580.8 | 7,224 | Direct | |
| Jul 27, 2021 | Common Stock | SSaleDisposed | −7,224 | $17.39F4 | −$125,625.36 | 0 | Direct | |
| Jul 28, 2021 | Common Stock | MOption exerciseAcquired | +15,000 | $1.44 | +$21,600 | 15,000 | Direct | |
| Jul 28, 2021 | Common Stock | SSaleDisposed | −15,000 | $17.50F5 | −$262,500 | 0 | Direct | |
| Jul 29, 2021 | Common Stock | MOption exerciseAcquired | +15,000 | $1.44 | +$21,600 | 15,000 | Direct | |
| Jul 29, 2021 | Common Stock | SSaleDisposed | −15,000 | $17.18F6 | −$257,700 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2021 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 148,747 | Direct | |
| Jul 28, 2021 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 133,747 | Direct | |
| Jul 29, 2021 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 118,747 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Weighted average price. These shares were sold in multiple transactions at prices ranging from $16.2600 to $17.2500 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Referenced by the price of 1 transaction in Table I.
- F4
Weighted average price. These shares were sold in multiple transactions at prices ranging from $17.2600 to $17.7500 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Referenced by the price of 1 transaction in Table I.
- F5
Weighted average price. These shares were sold in multiple transactions at prices ranging from $16.9800 to $17.8450 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Referenced by the price of 1 transaction in Table I.
- F6
Weighted average price. These shares were sold in multiple transactions at prices ranging from $17.0600 to $17.6250 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Referenced by the price of 1 transaction in Table I.